FAIR VALUE MEASUREMENT - Narrative (Details) $ / shares in Units, $ / shares in Units, $ in Thousands, $ in Millions			3 Months Ended		12 Months Ended
	Feb. 12, 2024 USD ($)	Mar. 02, 2021 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2021 USD ($)	Mar. 31, 2024 $ / shares	Dec. 31, 2023 USD ($)	Apr. 06, 2023 USD ($) $ / shares shares	Nov. 14, 2022 USD ($)	Nov. 14, 2022 CAD ($) $ / shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in fair value of financial instruments			$ (1,860)	$ 5,382
Investment in unconsolidated entity			10,200				$ 11,000
Debt interest rate conversion feature			$ 800				$ 872
Derivative Asset, Statement of Financial Position [Extensible Enumeration]			SBH purchase option and other derivative assets				SBH purchase option and other derivative assets
Debt conversion option			$ 3,200				$ 3,213
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]			Derivative and other long-term liabilities
Purchase option		$ 8,000			$ 8,000
Purchase option, term					5 years
Purchase option, extension term					2 years
Warrant, percentage of outstanding shares					10.00%
Warrants expiration period					60 days
Gain (loss) on change in fair value of purchase option			$ (951)	(300)
Stanley Brothers USA Holdings purchase option			779				1,730
Debt Conversion Option
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (loss) related to debt conversion			(56)	6,257
Debt conversion option			3,200				3,213
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in unconsolidated entity			10,200				11,000
Debt interest rate conversion feature			800				872
Debt conversion option			0				0
Stanley Brothers USA Holdings purchase option			779				1,730
Debt Interest Rate Conversion Feature
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (loss) related to debt conversion			(54)	$ (605)
BAT Group
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt instrument, convertible, ownership percentage of shares									19.90%	19.90%
Debt instrument, convertible, conversion price | $ / shares										$ 2.00
BAT Group | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt instrument, annual increase, accrued interest									5.00%	5.00%
BAT Group | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt instrument, annual increase, accrued interest									1.50%	1.50%
BAT Group | Convertible Notes Payable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount			$ 59,544				60,116		$ 56,800	$ 75.3
Debt instrument, convertible, ownership percentage of shares			19.90%
Debt instrument, convertible, conversion price | $ / shares						$ 2.00
DeFloria
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method ownership percentage								50.00%
British American Tobacco | DeFloria
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred units ownership percentage								100.00%
AJNA Biosciences | DeFloria
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method ownership percentage								50.00%
DeFloria
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants outstanding (in shares) | shares								400,000
Change in fair value of financial instruments			$ (800)
Investment in unconsolidated entity			$ 10,200				$ 11,000
DeFloria | Common Class A
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of warrant or right, number of securities called by warrants or rights (in shares) | shares								865,052
Warrants exercise price (in cad or usd per share) | $ / shares								$ 2.89
DeFloria | British American Tobacco
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred units outstanding (in shares) | shares								200,000
Capital contributed								$ 10,000
Payment for convertible debt	$ 3,000
DeFloria | AJNA Biosciences
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants outstanding (in shares) | shares								400,000